Sun Pharma’s CEQUA shows sustained dry eye disease improvement in Phase 4 study

Sun Pharmaceutical Industries Limited has made a significant announcement regarding its groundbreaking product, CEQUA (cyclosporine ophthalmic solution) 0.09%. The company has unveiled Phase 4 data ... Read More